Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

GZPHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$3,001$4,259$4,253$3,969
Dep. & Amort.$875$929$744$677
Deferred Tax$0-$53-$8$3
Stock-Based Comp.$0$0$0$0
Change in WC-$1,028-$1,372$1,879$860
Other Non-Cash$594$340$123$167
Operating Cash Flow$3,442$4,104$6,999$5,673
Investing Activities
PP&E Inv.-$1,128-$1,628-$1,384-$1,255
Net Acquisitions-$2$0-$2$31
Inv. Purchases-$6,546-$4,306-$6,918-$402
Inv. Sales/Matur.$1,709$2,421$899$688
Other Inv. Act.$2$398$151$7
Investing Cash Flow-$5,964-$3,115-$7,253-$932
Financing Activities
Debt Repay.$1,563$226$1,274-$117
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$2,251-$1,585-$1,117-$875
Other Fin. Act.-$319-$619$263-$111
Financing Cash Flow-$1,006-$1,978$46-$1,494
Forex Effect$7$8-$1$0
Net Chg. in Cash-$3,521-$981-$209$3,248
Supplemental Information
Beg. Cash$19,824$20,805$21,013$17,765
End Cash$16,303$19,824$20,805$21,013
Free Cash Flow$2,314$2,475$5,615$4,419
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) Financial Statements & Key Stats | AlphaPilot